Clinical Trials · NCT05617664
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Benha University
- Enrollment
- 150
- Start date
- Nov 2022
- Locations
- 1 site, Egypt
- Primary endpoint
- nocturnal enuresis improvement rate